Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia.

Hraoui M, Boutiba-Ben Boubaker I, Rachdi M, Slim A, Ben Redjeb S.

J Med Microbiol. 2012 Aug;61(Pt 8):1109-13. doi: 10.1099/jmm.0.037853-0. Epub 2012 Apr 26.

PMID:
22538994
2.

Macrolide- and tetracycline-resistance determinants of colonizing group B streptococcus in women in Egypt.

Shabayek S, Abdalla S.

J Med Microbiol. 2014 Oct;63(Pt 10):1324-7. doi: 10.1099/jmm.0.077057-0. Epub 2014 Jul 22.

PMID:
25053798
3.

A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.

Malbruny B, Werno AM, Anderson TP, Murdoch DR, Leclercq R.

J Antimicrob Chemother. 2004 Dec;54(6):1040-4. Epub 2004 Nov 10.

PMID:
15537693
4.

[Serotypes and antimicrobial susceptibility of Streptococcus agalactiae].

Martínez MA, Ovalle A, Durán C, Reid I, Urriola G, Garay B, Cifuentes M.

Rev Med Chil. 2004 May;132(5):549-55. Spanish.

PMID:
15279140
5.

Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.

Uh Y, Shin DH, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY.

J Antimicrob Chemother. 2004 Jun;53(6):1095-7. Epub 2004 Apr 29.

PMID:
15117924
6.

Molecular mechanisms of tetracycline and macrolide resistance and emm characterization of Streptococcus pyogenes isolates in Tunisia.

Hraoui M, Boutiba-Ben Boubaker I, Doloy A, Ben Redjeb S, Bouvet A.

Microb Drug Resist. 2011 Sep;17(3):377-82. doi: 10.1089/mdr.2010.0160. Epub 2011 May 25.

PMID:
21612508
7.

Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae in Tunisia.

Rachdi M, Boutiba-Ben Boubaker I, Moalla S, Smaoui H, Hammami A, Kechrid A, Ben Redjeb S.

Pathol Biol (Paris). 2008 May;56(3):125-9. Epub 2007 Jun 28.

PMID:
17604572
8.

Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.

Montanari MP, Cochetti I, Mingoia M, Varaldo PE.

Antimicrob Agents Chemother. 2003 Jul;47(7):2236-41.

9.

Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae.

Nakamura PA, Schuab RB, Neves FP, Pereira CF, Paula GR, Barros RR.

Mem Inst Oswaldo Cruz. 2011 Mar;106(2):119-22.

10.

Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.

Ergin A, Ercis S, Hasçelik G.

J Antimicrob Chemother. 2006 Jan;57(1):139-41. Epub 2005 Nov 16.

PMID:
16291867
11.

Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).

Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.

J Antimicrob Chemother. 2007 Oct;60(4):733-40. Epub 2007 Aug 2.

PMID:
17673477
12.

Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A.

Antimicrob Agents Chemother. 2001 Dec;45(12):3504-8.

13.

Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.

Culebras E, Rodriguez-Avial I, Betriu C, Redondo M, Picazo JJ.

Antimicrob Agents Chemother. 2002 May;46(5):1574-6.

14.

Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.

Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY.

Antimicrob Agents Chemother. 2004 Jul;48(7):2716-8.

15.

Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family.

Florindo C, Viegas S, Paulino A, Rodrigues E, Gomes JP, Borrego MJ.

Clin Microbiol Infect. 2010 Sep;16(9):1458-63. doi: 10.1111/j.1469-0691.2009.03106.x.

16.

Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.

Calatayud L, Ardanuy C, Cercenado E, Fenoll A, Bouza E, Pallares R, Martín R, Liñares J.

Antimicrob Agents Chemother. 2007 Sep;51(9):3240-6. Epub 2007 Jul 2.

17.

Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.

Giovanetti E, Montanari MP, Mingoia M, Varaldo PE.

Antimicrob Agents Chemother. 1999 Aug;43(8):1935-40.

18.

Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.

Green M, Martin JM, Barbadora KA, Beall B, Wald ER.

Antimicrob Agents Chemother. 2004 Feb;48(2):473-6.

19.

Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes.

Aracil B, Miñambres M, Oteo J, De La Rosa M, Gómez-Garcés JL, Alós AJ.

Clin Microbiol Infect. 2002 Nov;8(11):745-8.

20.

[Macrolide resistance phenotypes and genotypes in group G streptococci].

Açikgöz ZC, Göçer S, Almayanlar E.

Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):117-24. Turkish.

PMID:
14593892

Supplemental Content

Support Center